A major shareholder of Hyundai Bioscience reported a decrease of 172,562 shares in holdings of Hyundai Bioscience stock.

A major shareholder of Hyundai Bioscience filed a report on specified securities held by executives and major shareholders of Hyundai Bioscience dated Oct 13, 2026. The filing states holdings of 9,379,087 shares (9.72%) after the reported change. The reported trade may have taken place before the filing date.

Written in code from the structured data of the filing. Reference information, not investment advice.

Key figures

Reporting person

Major shareholder

Shares held after the report

9,379,087 shares

Ownership after the report

9.72%

Change in shares

-172,562 shares

Change in ownership

-0.18 percentage points

Report date

Oct 13, 2026

Filing facts

Filing type

Insider Ownership Report

Report name

Report on Specified Securities Held by Executives and Major Shareholders

Filed

Oct 13, 2026

Receipt number

20261013000243